The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 91, Issue , 2016, Pages 114-122

  Francis Stuart, Samantha D ^a   De Jesus, Nicole M ^a   Lindsey, Merry L ^b   Ripplinger, Crystal M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Arrhythmia; Fibrosis; Inflammation; Myocardial infarction

Indexed keywords

ANTIARRHYTHMIC AGENT; CHEMOKINE; COLLAGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; CALCIUM; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARRHYTHMOGENESIS; CELL ACTIVATION; CELL ACTIVITY; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; COLLAGEN FIBER; CYTOKINE PRODUCTION; ELECTROPHYSIOLOGY; ENZYME INHIBITION; FIBROSING ALVEOLITIS; FIBROSIS; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMMUNOCOMPETENT CELL; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFLAMMATION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; ANIMAL; CARDIAC MUSCLE; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; ION TRANSPORT; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; ION TRANSPORT; MATRIX METALLOPROTEINASES; MYOCARDIAL INFARCTION; MYOCARDIUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84953313607     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.12.024     Document Type: Review

References (90)

1. Frangogiannis N.G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 2014, 11:255-265. 10.1038/nrcardio.2014.28.
2. Lambert J.M., Lopez E.F., Lindsey M.L. Macrophage roles following myocardial infarction. Int. J. Cardiol. 2008, 130:147-158. 10.1016/j.ijcard.2008.04.059.
3. Dobaczewski M., Xia Y., Bujak M., Gonzalez-Quesada C., Frangogiannis N.G. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am. J. Pathol. 2010, 176:2177-2187. 10.2353/ajpath.2010.090759.
4. Cochain C., Auvynet C., Poupel L., Vilar J., Dumeau E., Richart A., et al. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2206-2213. 10.1161/ATVBAHA.112.254409.
5. Iyer R.P., Patterson N.L., Zouein F.A., Ma Y., Dive V., de Castro Brás L.E., et al. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int. J. Cardiol. 2015, 185:198-208. 10.1016/j.ijcard.2015.03.054.
6. van Amerongen M.J., Harmsen M.C., van Rooijen N., Petersen A.H., van Luyn M.J.A. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 2007, 170:818-829. 10.2353/ajpath.2007.060547.
7. Karagueuzian H.S. Targeting cardiac fibrosis: a new frontier in antiarrhythmic therapy?. Am. J Cardiovasc. Dis. 2011, 1:101-109.
8. Kohl P., Gourdie R.G. Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue?. J. Mol. Cell. Cardiol. 2014, 70:37-46. 10.1016/j.yjmcc.2013.12.024.
9. Lue W.M., Boyden P.A. Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current. Circulation 1992, 85:1175-1188.
10. Pinto J.M., Boyden P.A. Electrical remodeling in ischemia and infarction. Cardiovasc. Res. 1999, 42:284-297.
11. Peters N.S., Coromilas J., Severs N.J., Wit A.L. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997, 95:988-996.
12. Yao J.-A., Hussain W., Patel P., Peters N.S., Boyden P.A., Wit A.L. Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts. Circ. Res. 2003, 92:437-443. 10.1161/01.RES.0000059301.81035.06.
13. Pu J., Robinson R.B., Boyden P.A. Abnormalities in Ca(i)handling in myocytes that survive in the infarcted heart are not just due to alterations in repolarization. J. Mol. Cell. Cardiol. 2000, 32:1509-1523. 10.1006/jmcc.2000.1184.
14. 2+ in Arrhythmias in the Postmyocardial Infarction Heart 2011, Springer Berlin Heidelberg, Berlin, Heidelberg, pp. (305-22). 10.1007/978-3-642-17575-6_16. O.N. Tripathi, U. Ravens, M.C. Sanguinetti (Eds.).
15. Streitner F., Kuschyk J., Veltmann C., Brueckmann M., Streitner I., Brade J., et al. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients-a pilot study. Cytokine 2007, 40:30-34. 10.1016/j.cyto.2007.07.187.
16. Streitner F., Kuschyk J., Veltmann C., Ratay D., Schoene N., Streitner I., et al. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Cytokine 2009, 47:166-172. 10.1016/j.cyto.2009.06.003.
17. Maradit-Kremers H., Crowson C.S., Nicola P.J., Ballman K.V., Roger V.L., Jacobsen S.J., et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005, 52:402-411. 10.1002/art.20853.
18. Panizzi P., Swirski F.K., Figueiredo J.-L., Waterman P., Sosnovik D.E., Aikawa E., et al. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J. Am. Coll. Cardiol. 2010, 55:1629-1638. 10.1016/j.jacc.2009.08.089.
19. Yabluchanskiy A., Ma Y., DeLeon-Pennell K.Y., Altara R., Halade G.V., Voorhees A.P., et al. Myocardial infarction superimposed on aging: MMP-9 deletion promotes M2 macrophage polarization. J. Gerontol. A Biol. Sci. Med. Sci. 2015, 10.1093/gerona/glv034.
20. DeLeon-Pennell K.Y., de Castro Brás L.E., Iyer R.P., Bratton D.R., Jin Y.-F., Ripplinger C.M., et al. P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9. J. Mol. Cell. Cardiol. 2014, 76C:218-226. 10.1016/j.yjmcc.2014.09.007.
21. London B., Baker L.C., Lee J.S., Shusterman V., Choi B.-R., Kubota T., et al. Calcium-dependent arrhythmias in transgenic mice with heart failure. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H431-H441. 10.1152/ajpheart.00431.2002.
22. Petkova-Kirova P.S., Gursoy E., Mehdi H., McTiernan C.F., London B., Salama G. Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H2098-H2107. 10.1152/ajpheart.00097.2005.
23. Fernández-Velasco M., Ruiz-Hurtado G., Hurtado O., Moro M.A., Delgado C. TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H238-H245. 10.1152/ajpheart.01122.2006.
24. + current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts. Circ. J. 2006, 70:605-609.
25. Wang J., Wang H., Zhang Y., Gao H., Nattel S., Wang Z. Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator. J. Biol. Chem. 2004, 279:13289-13292. 10.1074/jbc.C400025200.
26. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992, 257:387-389.
27. Greensmith D.J., Nirmalan M. The effects of tumor necrosis factor-alpha on systolic and diastolic function in rat ventricular myocytes. Phys. Rep. 2013, 1. 10.1002/phy2.93.
28. 2+ ATPase. Crit. Care Med. 2011, 39:984-992. 10.1097/CCM.0b013e31820a91b9.
29. 2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium 2010, 47:378-386. 10.1016/j.ceca.2010.02.002.
30. Sawaya S.E., Rajawat Y.S., Rami T.G., Szalai G., Price R.L., Sivasubramanian N., et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1561-H1567. 10.1152/ajpheart.00285.2006.
31. Fernandez-Cobo M., Gingalewski C., Drujan D., De Maio A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine 1999, 11:216-224. 10.1006/cyto.1998.0422.
32. Saxena A., Chen W., Su Y., Rai V., Uche O.U., Li N., et al. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J. Immunol. 2013, 191:4838-4848. 10.4049/jimmunol.1300725.
33. Guillén I., Blanes M., Gómez-Lechón M.J., Castell J.V. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am. J. Phys. 1995, 269:R229-R235.
34. 2+ current by interleukin-1 beta in cultured rat ventricular myocytes. Am. J. Phys. 1995, 268:C339-C349.
35. 2+ current in adult rat ventricular myocytes. Am. J. Phys. 1997, 272:H2591-H2598.
36. 2+ current through protein kinase Cε activation in mouse heart. J. Biol. Chem. 2014, 289:21896-21908. 10.1074/jbc.M114.549642.
37. Li Y.H., Rozanski G.J. Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells. Cardiovasc. Res. 1993, 27:525-530.
38. 2+ current by IL-1beta in rat ventricular myocytes. Am. J. Phys. 1999, 276:H141-H148.
39. Combes A., Frye C.S., Lemster B.H., Brooks S.S., Watkins S.C., Feldman A.M., et al. Chronic exposure to interleukin 1beta induces a delayed and reversible alteration in excitation-contraction coupling of cultured cardiomyocytes. Pflugers Arch. 2002, 445:246-256. 10.1007/s00424-002-0921-y.
40. Duncan D.J., Hopkins P.M., Harrison S.M. Negative inotropic effects of tumour necrosis factor-alpha and interleukin-1beta are ameliorated by alfentanil in rat ventricular myocytes. Br. J. Pharmacol. 2007, 150:720-726. 10.1038/sj.bjp.0707147.
41. Thaik C.M., Calderone A., Takahashi N., Colucci W.S. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J. Clin. Invest. 1995, 96:1093-1099. 10.1172/JCI118095.
42. McTiernan C.F., Lemster B.H., Frye C., Brooks S., Combes A., Feldman A.M. Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. Circ. Res. 1997, 81:493-503.
43. Patten M., Hartogensis W.E., Long C.S. Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes. J. Biol. Chem. 1996, 271:21134-21141.
44. John G.R., Scemes E., Suadicani S.O., Liu J.S., Charles P.C., Lee S.C., et al. IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11613-11618.
45. Baum J.R., Long B., Cabo C., Duffy H.S. Myofibroblasts cause heterogeneous Cx43 reduction and are unlikely to be coupled to myocytes in the healing canine infarct. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H790-H800. 10.1152/ajpheart.00498.2011.
46. Baum J.R., Dolmatova E., Tan A., Duffy H.S. Omega 3 fatty acid inhibition of inflammatory cytokine-mediated Connexin43 regulation in the heart. Front. Physiol. 2012, 3:272. 10.3389/fphys.2012.00272/abstract.
47. De Jesus N.M., Wang L., Herren A.W., Wang J., Shenasa F., Bers D.M., et al. Atherosclerosis exacerbates arrhythmia following myocardial infarction: role of myocardial inflammation. Heart Rhythm. 2015, 12:169-178. 10.1016/j.hrthm.2014.10.007.
48. 2+]i transient, and APD increase in cardiomyocytes. J. Mol. Cell. Cardiol. 2007, 43:710-716. 10.1016/j.yjmcc.2007.09.004.
49. Tanaka T., Kanda T., Takahashi T., Saegusa S., Moriya J., Kurabayashi M. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J. Int. Med. Res. 2004, 32:57-61.
50. Yu X.-W., Chen Q., Kennedy R.H., Liu S.J. Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes. J. Physiol. Lond. 2005, 566:327-340. 10.1113/jphysiol.2005.086686.
51. Parrish D.C., Alston E.N., Rohrer H., Hermes S.M., Aicher S.A., Nkadi P., et al. Absence of gp130 in dopamine beta-hydroxylase-expressing neurons leads to autonomic imbalance and increased reperfusion arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H960-H967. 10.1152/ajpheart.00409.2009.
52. Lindsey M.L., Escobar G.P., Mukherjee R., Goshorn D.K., Sheats N.J., Bruce J.A., et al. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 2006, 113:2919-2928. 10.1161/CIRCULATIONAHA.106.612960.
53. Wu X., Huang W., Luo G., Alain L.A. Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling. Mol. Cell. Biochem. 2013, 384:155-162. 10.1007/s11010-013-1793-5.
54. Mukherjee R., Colbath G.P., Justus C.D., Bruce J.A., Allen C.M., Hewett K.W., et al. Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury. FASEB J. 2010, 24:3819-3828. 10.1096/fj.10-155531.
55. Mohammad G., Kowluru R.A. Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2011, 52:3832-3841. 10.1167/iovs.10-6368.
56. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74:184-195. 10.1016/j.cardiores.2006.10.002.
57. Ripplinger C.M., Lou Q., Li W., Hadley J., Efimov I.R. Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: implications for low-voltage cardioversion. Heart Rhythm. 2009, 6:87-97. 10.1016/j.hrthm.2008.09.019.
58. Nguyen T.P., Qu Z., Weiss J.N. Cardiac fibrosis and arrhythmogenesis: the road to repair is paved with perils. J. Mol. Cell. Cardiol. 2014, 70:83-91. 10.1016/j.yjmcc.2013.10.018.
59. Dhein S., Seidel T., Salameh A., Jozwiak J., Hagen A., Kostelka M., et al. Remodeling of cardiac passive electrical properties and susceptibility to ventricular and atrial arrhythmias. Front. Physiol. 2014, 5:424. 10.3389/fphys.2014.00424.
60. Xie Y., Sato D., Garfinkel A., Qu Z., Weiss J.N. So little source, so much sink: requirements for afterdepolarizations to propagate in tissue. Biophys. J. 2010, 99:1408-1415. 10.1016/j.bpj.2010.06.042.
61. Myles R.C., Wang L., Kang C., Bers D.M., Ripplinger C.M. Local β-adrenergic stimulation overcomes source-sink mismatch to generate focal arrhythmia. Circ. Res. 2012, 110:1454-1464. 10.1161/CIRCRESAHA.111.262345.
62. Morita N., Sovari A.A., Xie Y., Fishbein M.C., Mandel W.J., Garfinkel A., et al. Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1594-H1605. 10.1152/ajpheart.00579.2009.
63. Tschabrunn C.M., Roujol S., Nezafat R., Faulkner-Jones B., Buxton A.E., Josephson M.E., et al. A swine model of infarct-related reentrant ventricular tachycardia: electroanatomic, magnetic resonance, and histopathological characterization. Heart Rhythm. 2015, 10.1016/j.hrthm.2015.07.030.
64. van den Borne S.W.M., Díez J., Blankesteijn W.M., Verjans J., Hofstra L., Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 2010, 7:30-37. 10.1038/nrcardio.2009.199.
65. Gaudesius G., Miragoli M., Thomas S.P., Rohr S. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ. Res. 2003, 93:421-428. 10.1161/01.RES.0000089258.40661.0C.
66. Chilton L., Giles W.R., Smith G.L. Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J. Physiol. Lond. 2007, 583:225-236. 10.1113/jphysiol.2007.135038.
67. Miragoli M., Gaudesius G., Rohr S. Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ. Res. 2006, 98:801-810. 10.1161/01.RES.0000214537.44195.a3.
68. Camelliti P., Devlin G.P., Matthews K.G., Kohl P., Green C.R. Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovasc. Res. 2004, 62:415-425. 10.1016/j.cardiores.2004.01.027.
69. Xie Y., Garfinkel A., Camelliti P., Kohl P., Weiss J.N., Qu Z. Effects of fibroblast-myocyte coupling on cardiac conduction and vulnerability to reentry: a computational study. Heart Rhythm. 2009, 6:1641-1649. 10.1016/j.hrthm.2009.08.003.
70. McDowell K.S., Arevalo H.J., Maleckar M.M., Trayanova N.A. Susceptibility to arrhythmia in the infarcted heart depends on myofibroblast density. Biophys. J. 2011, 101:1307-1315. 10.1016/j.bpj.2011.08.009.
71. Nattel S., Andrade J., Macle L., Rivard L., Dyrda K., Mondesert B., et al. New directions in cardiac arrhythmia management: present challenges and future solutions. Can. J. Cardiol. 2014, 30:S420-S430. 10.1016/j.cjca.2014.09.027.
72. Waldo A.L., Camm A.J., deRuyter H., Friedman P.L., DJ M.N., Pauls J.F., et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD investigators. Survival with oral d-sotalol. Lancet 1996, 348:7-12.
73. Hammerman H., Kloner R.A., Schoen F.J., Brown E.J., Hale S., Braunwald E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 1983, 67:1290-1295.
74. Giugliano G.R., Giugliano R.P., Gibson C.M., Kuntz R.E. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am. J. Cardiol. 2003, 91:1055-1059. 10.1016/S0002-9149(03)00148-6.
75. American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 2013, 61:e78-140. 10.1016/j.jacc.2012.11.019.
76. Moliterno D.J., Smyth S.S. Tissue necrosis factor α and targeting its receptor in ischaemic heart disease. Heart 2013, 99:1305-1306. 10.1136/heartjnl-2013-303960.
77. Kurrelmeyer K.M., Michael L.H., Baumgarten G., Taffet G.E., Peschon J.J., Sivasubramanian N., et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5456-5461. 10.1073/pnas.070036297.
78. Abbate A., Kontos M.C., Grizzard J.D., Biondi-Zoccai G.G.L., Van Tassell B.W., Robati R., et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] pilot study). Am. J. Cardiol. 2010, 105:1371-1. 10.1016/j.amjcard.2009.12.059.
79. Abbate A., Van Tassell B.W., Seropian I.M., Toldo S., Robati R., Varma A., et al. Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse. Eur. J. Heart Fail. 2010, 12:319-322. 10.1093/eurjhf/hfq017.
80. Van Tassell B.W., Varma A., Salloum F.N., Das A., Seropian I.M., Toldo S., et al. Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice. J. Cardiovasc. Pharmacol. 2010, 55:117-122. 10.1097/FJC.0b013e3181c87e53.
81. Ridker P.M., Thuren T., Zalewski A., Libby P. Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS). Am. Heart J. 2011, 162:597-605. 10.1016/j.ahj.2011.06.012.
82. Dobaczewski M., Bujak M., Li N., Gonzalez-Quesada C., Mendoza L.H., Wang X.-F., et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 2010, 107:418-428. 10.1161/CIRCRESAHA.109.216101.
83. Bujak M., Ren G., Kweon H.J., Dobaczewski M., Reddy A., Taffet G., et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007, 116:2127-2138. 10.1161/CIRCULATIONAHA.107.704197.
84. Nguyen D.T., Ding C., Wilson E., Marcus G.M., Olgin J.E. Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias. Heart Rhythm. 2010, 7:1438-1445. 10.1016/j.hrthm.2010.04.030.
85. Lindsey M.L., Zamilpa R. Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc. Ther. 2012, 30:31-41. 10.1111/j.1755-5922.2010.00207.x.
86. Wang G.-Y., Bergman M.R., Nguyen A.P., Turcato S., Swigart P.M., Rodrigo M.C., et al. Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility. Cardiovasc. Res. 2006, 69:688-696. 10.1016/j.cardiores.2005.08.023.
87. Lemaître V., O'Byrne T.K., Dalal S.S., Tall A.R., D'Armiento J.M. Macrophage-specific expression of human collagenase (MMP-1) in transgenic mice. Ann. N. Y. Acad. Sci. 1999, 878:736-739.
88. Yabluchanskiy A., Li Y., Chilton R.J., Lindsey M.L. Matrix metalloproteinases: drug targets for myocardial infarction. Curr. Drug Targets 2013, 14:276-286.
89. Tang Z., McGowan B.S., Huber S.A., McTiernan C.F., Addya S., Surrey S., et al. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. J. Mol. Cell. Cardiol. 2004, 36:515-530. 10.1016/j.yjmcc.2004.01.008.
90. Hatada K., Washizuka T., Horie M., Watanabe H., Yamashita F., Chinushi M., et al. Tumor necrosis factor-alpha inhibits the cardiac delayed rectifier K current via the asphingomyelin pathway. Biochem. Biophys. Res. Commun. 2006, 344:189-193. 10.1016/j.bbrc.2006.03.115.